Cardiac masses are rare, but remain an important component of cardio-oncology practice.
These include benign tumors, malignant tumors (primary and secondary) and tumor-like …

Abstract Purpose of Review Cardiac masses frequently present significant diagnostic and
therapeutic clinical challenges and encompass a broad set of lesions that can be either …

Cardiovascular (CV) imaging is an important tool in baseline risk assessment and detection
of CV disease in oncology patients receiving cardiotoxic cancer therapies. This position …

Abstract The Society for Cardiovascular Magnetic Resonance (SCMR) last published its
comprehensive expert panel report of clinical indications for CMR in 2004. This new …

Cardiovascular disease (CVD) is the leading single cause of morbidity and mortality,
causing over 17. 9 million deaths worldwide per year with associated costs of over $800 …

Cardiac tumours are a rare, but often devastating, clinical diagnosis. They encompass a
broad set of lesions that include both neoplastic and non-neoplastic conditions. Cardiac …

Cardiac amyloidosis can affect all cardiac chambers. The infiltrative process results in
biventricular wall thickening, systolic and diastolic ventricular dysfunction, and low cardiac …

Cine cardiac magnetic resonance imaging (MRI) is widely used for the diagnosis of cardiac
diseases thanks to its ability to present cardiovascular features in excellent contrast. As …

Cardiac masses include tumours, thrombi, vegetations, calcific lesions and other rare
conditions. Unlike most other organs, the malignant behaviour in the heart has …

Degradability of biomaterials brings many opportunities as well as great challenges to their
clinical applications. However, reports of systematic in vivo biodegradation are rather limited …